David Shaw’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
David Shaw's ONC Position: Q3 2026 in Review
David Shaw opened a new position in BeOne Medicines (ONC) in Q3 2026: 745 shares worth $273K. The stake represents ﹤0.01% of the portfolio and ranks #4528 among its holdings. This is a return to the name: David Shaw previously reported a position in ONC as recently as Q2 2025.
David Shaw first reported a position in ONC in Q1 2017 and has held it in 11 quarters since. The position peaked at $38.3M in Q2 2025. 325 funds tracked by Wall St. Rank hold ONC as of Q3 2026.
- David Shaw held 745 shares of BeOne Medicines worth $273K as of Q3 2026.
- BeOne Medicines was a new David Shaw position in Q3 2026.
- BeOne Medicines made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4528 holding.
- David Shaw first reported a position in BeOne Medicines in Q1 2017 and has held it in 11 quarters since.
- David Shaw's BeOne Medicines position peaked at $38.3M in Q2 2025.
- 325 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.